Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance"
- PMID: 41084206
- PMCID: PMC12710548
- DOI: 10.1111/1346-8138.17976
Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance"
Erratum for
-
Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.J Dermatol. 2025 May;52(5):787-801. doi: 10.1111/1346-8138.17695. Epub 2025 Mar 13. J Dermatol. 2025. PMID: 40079483 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
